Could stem cells plus supercharged immune cells tame autoimmune disease?
NCT ID NCT06435897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests whether combining mesenchymal stem cells (MSCs) with specially engineered immune cells (CAR-T cells) is safe and can help control autoimmune diseases. About 30 adults with established autoimmune conditions will receive the treatment and be monitored for side effects and symptom changes. The goal is to see if this combination can reduce or stabilize disease activity, not to cure the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shenzhen Geno-immune Medical Institute
RECRUITINGShenzhen, Guangdong, 518000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a metabolic modulator help people with type 1 diabetes use insulin better?
- Could a week of antibiotics stop joint infections after replacement surgery?
- Engineered immune cells take aim at childhood autoimmune diseases
- Engineered immune cells take aim at autoimmune diseases
- Protein clue could unlock new autoimmune treatments
- New blood filter could improve treatment for autoimmune diseases